“We need to break down the barriers between health institutions to allow patients and their trusted clinicians to access global data about individual patient treatment decisions and outcomes.” … A… Read more »
By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of… Read more »
Around the world, physicians are seeking better treatments for COVID-19. What can they learn from cancer research? Today, STAT published an article written by Cancer Commons founder Marty Tenenbaum, PhD,… Read more »
Erika Vial Monteverdi, Executive Director of Cancer CommonsCancer Commons is a patient-centric, nonprofit network of patients, physicians, and scientists that helps identify the best options for treating an individual’s cancer. Here, our Curious Dr. George asks executive… Read more »
Lola Rahib, PhD (left), and Conan Kinsey, MD, PhD (right), present our findings in San Diego, CAToday, our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, presented initial findings from our real-world data registry on a novel treatment combination for pancreatic cancer patients. Performed in… Read more »
In a new Q&A with the Precision Medicine World Conference, Executive Director Erika Vial Monteverdi outlines how Cancer Commons is helping people navigate their treatment, and shares her vision for the… Read more »
Cancer Commons has partnered with the Precision Medicine World Conference to organize a dedicated Patient Track at their meeting in Silicon Valley, CA, in January 2020. We’ve lined up a great… Read more »
Last week, Cancer Commons founder Marty Tenenbaum, PhD, shared our mission and impact at a fundraiser gala hosted by the Kids & Art Foundation in Palo Alto, CA. The theme of… Read more »
In this month’s issue of Gentry Magazine, executive director Erika Vial Monteverdi shares the incredible impact that Cancer Commons has had for patients, as well as our bold and unique… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak about Cancer Commons at the Stanford Medicine X | CHANGE conference this Sunday, September 22 at 9:15 am. The conference is a “premier gathering of patients,… Read more »